Sadhana Nitrochem Limited has informed the Exchange regarding Board meeting held on May 02, 2025 1. Appointed M/s. Chandrashekhar lyer & Co, (Firm Registration Number 114260W) as the Internal Auditor of the Company for the Financial Year 2025-26 to conduct the Internal Audit of the Company2.Appointed M/s. Vinay Mulay & Co, Cost Accountants, as Cost Auditor of the Company for theFinancial Year 2025-26 to conduct the Cost Audit of the Company3. Appointed M/s. Hetal Doshi & Associates, Secretarial Auditor of the Company for the FinancialYear 2025-26 to conduct the Secretarial Audit of the Company4. The Board noted the re-appointment of M/s. Jayesh Dadia & Associates LLP, CharteredAccountants (Registration No. 121142W/W100122), Statutory Auditor of the Company and theirremuneration as approved by the members of the company at the 51st Annual General Meetingheld on September 25, 20245. Considered and noted that the proceeds from the Right Issue amounting to Rs. 20.39 Crores arebeing utilised for the object of issue as contained in Letter of Offer till 31st March, 2025
SADHNANIQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, with statutory auditors issuing an unmodified opinion. For FY25, standalone revenue fell to Rs. 133.37 crore (from Rs. 188.86 crore, down ~29%), while standalone net profit dropped to Rs. 5.22 crore (from Rs. 7.41 crore). On a consolidated basis, revenue declined to Rs. 165.55 crore (from Rs. 190.05 crore) but net profit jumped sharply to Rs. 7.56 crore (from Rs. 4.08 crore, up ~85%), driven by subsidiary contributions. The board recommended a 10% dividend (Re. 0.10 per share of Re. 1 face value) subject to shareholder approval. Internal, cost, secretarial, and statutory auditors were appointed/re-appointed for FY25-26. The board also confirmed that Rs. 20.39 crore raised via the Right Issue has been used for the stated purpose as of March 31, 2025.
Mixed picture for shareholders — weak standalone performance with falling revenue and profit, but a strong rebound in consolidated earnings thanks to subsidiaries. The small dividend (10%) and confirmation that Right Issue funds were deployed as planned are positives, though the sharp standalone top-line decline is a concern that may weigh on the stock in the short term.